News
Moderna, Merck Say mRNA Vaccine Prevents Melanoma From Returning
Moderna and Merck say the experimental vaccine prevented the return and spread of the cancer in high-risk melanoma patients.
News and insights
Moderna
Business News
Ministry of Health, Labour and Welfare in Japan Approves Partial Change Application for Moderna’s COVID-19 mRNA Vaccine Targeting SARS-COV-2 Variant JN.1, Business News
On August 24, 2024, Moderna, Inc., a global leader in mRNA therapeutics, announced that Japan’s Ministry...